Claudio Brunstein is an Oncology physician. OpenAlex indexes 433 publications with 12,994 citations (h-index 56); ClinicalTrials.gov lists 15 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
University Of Minnesota Physicians
516 Delaware Street SE, Pwb Fifth Floor, Clinic 5b
Minneapolis, MN 55455
Telephone
612-273-2800Registry record last updated 17 Apr 2012.
Clinical trials
- Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
Sponsor: Benjamin Tomlinson
- Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
Sponsor: Masonic Cancer Center, University of Minnesota
- Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT
Sponsor: Masonic Cancer Center, University of Minnesota
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
- National Marrow Donor ProgramProgram year20241 payment
- Rigel Pharmaceuticals, Inc.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
32.9%Penicillins with extended spectrum10.2%Amoxicillin100%Part D<11 patientsShort-acting sulfonamides9.9%Sulfamethoxazole-Trimethoprim100%Part D<11 patients+ 2 more classes in this area
Dermatology
21.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor21.6%Acyclovir100%Part D≥18 patientsCancer & immunology
18.6%Kinase inhibitor5.1%Jakafi100%Part D<11 patientsThalidomide Analog4.8%Lenalidomide100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2017–2020 per NIH RePORTER. The latest:
- ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML
University of Minnesota
FY2020$184,800UG1HL069290 - ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML
University of Minnesota
FY2019$184,800UG1HL069290 - ALT-803 (IL-15/IL-15Rα-Fc) maintenance after allogeneic transplantation for AML
University of Minnesota
FY2018$175,560UG1HL069290
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”